InvestorsHub Logo
Followers 61
Posts 595
Boards Moderated 0
Alias Born 08/10/2014

Re: To infinity and beyond! post# 104254

Sunday, 05/24/2015 10:36:24 PM

Sunday, May 24, 2015 10:36:24 PM

Post# of 403510
Funny, To infinity..., I was thinking about the same thing. It's interesting how in the ECCMID Brilacidin presentation (slide 19/24) Dr. Jorgensen discusses the accuracy of PK-PD modeling and dose selection. It's not the first time he's mentioned the value of PK-PD modeling and dose selection. I suspect that this extended Phase 1 for Kevetrin is providing enough PK/PD data to make some pretty good predictions about Kevetrin dose and frequency for upcoming trials.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News